Cargando…

FAM111B Acts as an Oncogene in Bladder Cancer

SIMPLE SUMMARY: Bladder cancer can be categorized into non-muscle- and muscle-invasive bladder cancer based on the extent of invasion. While non-muscle-invasive bladder cancer is associated with a low mortality rate, it displays a high recurrence rate, and more than half of the patients are at risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ning, Peng, Lei, Yang, Jiaping, Li, Jinqian, Zhang, Sheng, Sun, Mingjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648174/ https://www.ncbi.nlm.nih.gov/pubmed/37958297 http://dx.doi.org/10.3390/cancers15215122

Ejemplares similares

Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes
por: Ip, Wing-Hang, et al.
Publicado: (2021)

Mutations of FAM111B gene are not associated with Systemic Sclerosis
por: Gcelu, A., et al.
Publicado: (2018)

N(6) ‐methyladenosine‐modified FAM111A‐DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A
por: Pu, Jian, et al.
Publicado: (2023)

Functions and evolution of FAM111 serine proteases
por: Welter, Allison L., et al.
Publicado: (2022)

Proposed Cellular Function of the Human FAM111B Protein and Dysregulation in Fibrosis and Cancer
por: Arowolo, Afolake, et al.
Publicado: (2022)

FAM111A is dispensable for electrolyte homeostasis in mice
por: Ilenwabor, Barnabas P., et al.
Publicado: (2022)

FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma
por: Sun, Haijun, et al.
Publicado: (2019)

Pan-Cancer Analysis of the Tumorigenic Effect and Prognostic Diagnostic Value of FAM111B in Human Carcinomas
por: Wu, Hengmiao, et al.
Publicado: (2023)

FAM111A Is a Novel Molecular Marker for Oocyte Aging
por: Yang, Huixia, et al.
Publicado: (2022)

FAM111B enhances proliferation of KRAS‐driven lung adenocarcinoma by degrading p16
por: Kawasaki, Keisuke, et al.
Publicado: (2020)

FAM111A regulates replication origin activation and cell fitness
por: Rios-Szwed, Diana O, et al.
Publicado: (2023)

Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer
por: Yuan, Xiaolei, et al.
Publicado: (2021)

DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis
por: Zhu, Xiang, et al.
Publicado: (2022)

Loss of FAM111B protease mutated in hereditary fibrosing poikiloderma negatively regulates telomere length
por: Kliszczak, Maciej, et al.
Publicado: (2023)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
por: Cipriano, Rocky, et al.
Publicado: (2013)

Identification of FAM111A as an SV40 Host Range Restriction and Adenovirus Helper Factor
por: Fine, Debrah A., et al.
Publicado: (2012)

Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations
por: Mercier, Sandra, et al.
Publicado: (2015)

FAM83 family oncogenes are broadly involved in human cancers: an integrative multi‐omics approach
por: Snijders, Antoine M., et al.
Publicado: (2017)

miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer
por: Feng, Yougang, et al.
Publicado: (2014)

GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process
por: Shen, Jingang, et al.
Publicado: (2020)

FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression
por: Hu, Wei-Min, et al.
Publicado: (2023)

FAM111 protease activity undermines cellular fitness and is amplified by gain‐of‐function mutations in human disease
por: Hoffmann, Saskia, et al.
Publicado: (2020)

Case Report: Diverse phenotypes of congenital poikiloderma associated with FAM111B mutations in codon 628: A case report and literature review
por: Wu, Yuhao, et al.
Publicado: (2022)

Case report: Discovery of a de novo FAM111B pathogenic variant in a patient with an APECED-like clinical phenotype
por: Ferré, Elise M. N., et al.
Publicado: (2023)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
por: Ji, Xiaoshuai, et al.
Publicado: (2020)

LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA‐135a binding site affects bladder cancer risk
por: Wang, Wei, et al.
Publicado: (2018)

FAM111A protects replication forks from protein obstacles via its trypsin-like domain
por: Kojima, Yusuke, et al.
Publicado: (2020)

Compound Heterozygous Variants in FAM111A Cause Autosomal Recessive Kenny-Caffey Syndrome Type 2
por: Eren, Erdal, et al.
Publicado: (2023)

The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert
por: Gu, Yan, et al.
Publicado: (2020)

IRF2 inhibits ZIKV replication by promoting FAM111A expression to enhance the host restriction effect of RFC3
por: Ren, Kai, et al.
Publicado: (2021)

[Retracted] FAM172A induces S phase arrest of HepG2 cells via Notch 3
por: Feng, Zhiqiang, et al.
Publicado: (2023)

FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
por: Guan, Jikui, et al.
Publicado: (2015)

FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter
por: QIAN, KAI, et al.
Publicado: (2016)

Proto-oncogene FAM83A contributes to casein kinase 1–mediated mitochondrial maintenance and white adipocyte differentiation
por: Huang, Kuilong, et al.
Publicado: (2022)

FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer
por: Kang, Ho-Won, et al.
Publicado: (2012)

Hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis: Hepatic disease in a child with a novel pathogenic variant of FAM111B
por: Dokic, Yelena, et al.
Publicado: (2020)

FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance
por: Bartel, Courtney A., et al.
Publicado: (2016)

[Retracted] FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter
por: Qian, Kai, et al.
Publicado: (2023)

Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo
por: Xie, Xudong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k2mdq8bedusdjsjh05os0n2ugk